The pharmaceutical industry has always been about more than profit margins and market share—it’s about the delicate balance between scientific innovation and human impact. Few leaders understand this duality better than Barbara Maglione, Head of R&D at Farmaceutici Damor, who has transformed a family business into a globally-focused enterprise while maintaining an unwavering commitment to patient-centric solutions.
Maglione’s journey into pharmaceuticals wasn’t born from ambition alone—it was rooted in purpose. Growing up watching her father’s dedication to medicine and his solid career in the pharmaceutical industry, she witnessed firsthand “the profound impact of improving people’s health.” This early exposure didn’t just spark her interest; it “instilled in me a deep sense of purpose and a desire to continue his work on a larger scale.”
Coming Home to Transform
The most pivotal moment in Maglione’s career came when she made a decision that would reshape both her future and her family’s legacy. After gaining valuable experience working abroad, she chose to return to Italy and take over the family business. “This was a pivotal moment not just for me, but for the company, as it marked the beginning of its transformation into a more modern, globally-focused enterprise,” she reflects.
This homecoming wasn’t merely about succession—it was about evolution. Maglione brought international perspectives and modern methodologies to a traditional family enterprise, proving that heritage and innovation aren’t mutually exclusive.
Resilience Through Crisis
When COVID-19 struck, many pharmaceutical companies scrambled to adapt. Maglione faced the challenge head-on with a philosophy that would define her leadership approach. “The mindset that helped me through this was a focus on resilience and innovation,” she explains. Rather than merely surviving the crisis, she viewed it as an opportunity to strengthen the company’s foundation.
“I believed that by investing in research and development and adapting our business model, we could not only survive but emerge stronger.” This period became a masterclass in “the importance of agility and long-term strategic thinking”—principles that continue to guide Farmaceutici Damor’s strategic decisions.
Beyond Products: Creating Solutions
Under Maglione’s leadership, Farmaceutici Damor operates with a clear vision: improving quality of life through science. The company’s key offerings span therapeutic solutions with particular strength in dermatology and gynecology. But what truly differentiates the company isn’t just what they make—it’s how they approach their work.
“We don’t just create products; we develop innovative solutions that address unmet medical needs,” Maglione emphasizes. This patient-centric philosophy drives every decision, from R&D investments to collaborations with medical professionals and research institutions. The goal isn’t simply effectiveness—it’s ensuring products are both “effective and safe.”
The Bioarginina® Gamble
Perhaps no decision better illustrates Maglione’s strategic thinking than her choice to relaunch bioarginina® with the bioarginina®C product. The move “required a substantial financial commitment and a long development timeline,” making it a significant risk for the company.
Yet Maglione’s confidence in the scientific data and the product’s potential to “meet a critical need” proved prescient. The successful launch not only “solidified our position as a leader in improving patient’s quality of life related to asthenia” but also “paved the way for future innovations in this sector.”
This calculated risk-taking exemplifies Maglione’s leadership philosophy: combining rigorous scientific analysis with bold strategic vision.
Empowering Through Example
Maglione’s approach to leadership extends beyond business strategy to human development. She fosters “a culture of collaboration and open communication,” believing in giving people autonomy and trusting them to make decisions. This approach helps team members “grow and take ownership of their work.”
For women in her field specifically, Maglione takes a proactive stance. “I make a conscious effort to mentor them and provide opportunities for leadership.” Her philosophy is rooted in demonstration rather than declaration: “I believe in leading by example, demonstrating that a woman can be a strong, effective leader while also valuing a balanced personal life.”
Breaking Barriers and Myths
When it comes to challenging perceptions about women in leadership, Maglione is direct and unapologetic. She targets one particular myth: “that women in leadership are overly emotional or lack the assertiveness needed to make tough decisions.”
“This is a stereotype that has no basis in reality,” she states firmly. Drawing from experience, she adds, “I have seen countless female leaders, myself included, who are strong, decisive, and strategic. Emotions, when managed effectively, can be a source of strength and empathy, allowing for a more nuanced and compassionate leadership style.”
Advice for the Next Generation
For young women aspiring to leadership roles, Maglione offers practical wisdom: “Embrace every opportunity to learn. Don’t be afraid to take risks and step outside of your comfort zone.” She emphasizes the importance of mentorship—both receiving and giving it—and perhaps most importantly: “Don’t let others’ perceptions define your potential. Believe in your own abilities and stay true to your values.”
Building a Lasting Legacy
Looking toward the future, Maglione envisions a legacy built on three pillars: “integrity, innovation, and purpose.” She wants to be remembered not just for Farmaceutici Damor’s growth, but “for my commitment to improving people’s health and for my efforts to create a more inclusive and supportive environment for women in the pharmaceutical industry.”
Her ultimate aspiration transcends personal achievement: “My ultimate hope is that my work inspires others to pursue their passions and make a positive impact on the world.”
Barbara Maglione represents a new generation of pharmaceutical leaders—one that seamlessly blends scientific rigor with human compassion, strategic thinking with authentic mentorship, and family legacy with global innovation. She’s not just running a company; she’s redefining what leadership looks like in an industry where science meets humanity.
